Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
7.10
+0.08 (1.14%)
At close: Sep 18, 2024, 4:00 PM
7.11
+0.01 (0.14%)
After-hours: Sep 18, 2024, 4:54 PM EDT
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $12.35 million as of September 19, 2024. Its market cap has decreased by -52.14% in one year.
Market Cap
12.35M
Enterprise Value
5.30M
1-Year Change
-52.14%
Ranking
Category
Stock Price
$7.10
Market Cap Chart
Since November 20, 2015, Purple Biotech's market cap has increased from $11.20M to $12.35M, an increase of 10.24%. That is a compound annual growth rate of 1.11%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 17, 2024 | 10.00M | -35.48% |
Dec 29, 2023 | 15.50M | -36.99% |
Dec 30, 2022 | 24.60M | -63.77% |
Dec 31, 2021 | 67.90M | 805.33% |
Dec 31, 2020 | 7.50M | -40.00% |
Dec 31, 2019 | 12.50M | 68.92% |
Dec 31, 2018 | 7.40M | -57.71% |
Dec 29, 2017 | 17.50M | 44.63% |
Dec 30, 2016 | 12.10M | 9.01% |
Dec 31, 2015 | 11.10M | -0.89% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Anew Medical | 12.58M |
STRATA Skin Sciences | 12.56M |
Cingulate | 11.77M |
Dominari Holdings | 11.77M |
BioRestorative Therapies | 11.69M |
Virax Biolabs Group | 11.25M |
QT Imaging Holdings | 11.20M |
GlycoMimetics | 10.96M |